Together these data suggest that targeting the dysfunctional HSF1-driven HSP chaperone system with PU-H71 significantly reduces oTau-induced pathology and neurodegeneration in AstTau, accentuating the involvement of HSPs in tauopathies. The gene discussed is HSP90B2P; the disease is tauopathy.